Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Net Income (2014 - 2025)

Mesoblast's (MEOBF) quarterly Net Income came in at -$102.1 million in Q2 2025, down 16.13% year-over-year from -$121.8 million in Q2 2024, and down 16.13% quarter-over-quarter from -$88.0 million in Q2 2024.

Analysis

Mesoblast (MEOBF) Net Income (2014 - 2025) Analysis & Trends

Mesoblast has disclosed Net Income across 12 years of filings, most recently posting -$102.1 million for Q2 2025.

  • In Q2 2025, Net Income fell 16.13% year-over-year to -$102.1 million; the TTM figure through Jun 2025 stood at -$253.4 million (down 99.9% YoY), while the FY2026 annual figure was -$57.5 million, up 43.71% from the prior year.
  • Net Income came in at -$102.1 million for Q2 2025 at Mesoblast, down from -$88.0 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $178.7 million in Q2 2021 to a low of -$102.1 million in Q2 2025.
  • Average Net Income over 5 years is -$7.6 million, with a median of -$19.2 million recorded in 2022.
  • Year-over-year, Net Income jumped 201.57% in 2021 and sank 281.68% in 2023.
  • Over 5 years, Net Income stood at $25.9 million in 2021, then fell by 5.62% to $24.5 million in 2022, then tumbled by 434.43% to -$81.9 million in 2023, then declined by 7.41% to -$88.0 million in 2024, then slipped by 16.13% to -$102.1 million in 2025.
  • Per Business Quant data, the three most recent Net Income figures were -$102.1 million in Q2 2025, -$88.0 million in Q2 2024, and -$81.9 million in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 54.77 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -91.19 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -47.29 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 77.80 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn -81.06 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -119.07 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 20.07 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -4.89 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 2.23 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -102.14 Mn
Jun 30, 2024 -87.96 Mn
Jun 30, 2023 -81.89 Mn
Mar 31, 2023 18.60 Mn
Dec 31, 2022 24.49 Mn
Sep 30, 2022 -16.88 Mn
Jun 30, 2022 -21.46 Mn
Mar 31, 2022 21.30 Mn
Dec 31, 2021 25.95 Mn
Sep 30, 2021 -22.65 Mn
Jun 30, 2021 178.71 Mn
Mar 31, 2021 -26.71 Mn
Dec 31, 2020 -25.54 Mn
Sep 30, 2020 -24.54 Mn
Mar 31, 2020 -57.65 Mn
Dec 31, 2019 -38.47 Mn
Sep 30, 2019 -5.48 Mn
Jun 30, 2019 -27.08 Mn
Mar 31, 2019 -29.38 Mn
Dec 31, 2018 -30.33 Mn